Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma

Published:2015-12 Issue:5 Volume:93 Page:976-985
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Chera Bhishamjit S.,Amdur Robert J.,Tepper Joel,Qaqish Bahjat,Green Rebecca,Aumer Shannon L.,Hayes Neil,Weiss Jared,Grilley-Olson Juneko,Zanation Adam,Hackman Trevor,Funkhouser William,Sheets Nathan,Weissler Mark,Mendenhall William

Funder

University of North Carolina

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference42 articles.

1. Human papillomavirus and rising oropharyngeal cancer incidence in the United States;Chaturvedi;J Clin Oncol,2011

2. Case-control study of human papillomavirus and oropharyngeal cancer;D'Souza;N Engl J Med,2007

3. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck;Mork;N Engl J Med,2001

4. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck;Westra;Clin Cancer Res,2008

5. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus;Braakhuis;J Natl Cancer Inst,2004

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment De-escalation in Oropharyngeal Carcinoma and the Role of Robotic Surgery;Surgical Oncology Clinics of North America;2024-10

2. De-Escalation Strategies in HPV-Associated Oropharynx Cancer: A Historical Perspective with Future Direction;Cancers;2024-08-01

3. Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment;Cancer Letters;2024-08

4. Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer;Critical Reviews in Oncology/Hematology;2024-04

5. De-escalating radiotherapy in HPV-positive oropharyngeal squamous cell carcinoma: how much is too little?;BMJ Case Reports;2024-01